Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report

BACKGROUND: Clear cell sarcoma (CCS), initially named malignant melanoma of soft parts, is an aggressive soft tissue sarcoma (STS) that, due to MITF activation, shares with melanoma the expression of melanocyte differentiation antigens. CCS is poorly sensitive to chemotherapy. Multi-kinase inhibitor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Tazzari, Marcella, Palassini, Elena, Vergani, Barbara, Villa, Antonello, Rini, Francesca, Negri, Tiziana, Colombo, Chiara, Crippa, Flavio, Morosi, Carlo, Casali, Paolo G, Pilotti, Silvana, Stacchiotti, Silvia, Rivoltini, Licia, Castelli, Chiara
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4342079/
https://ncbi.nlm.nih.gov/pubmed/25880253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1044-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados